Member Info for Ultrashort

Up to 13%, I'm surprised it's increased. So this rise has had little to do with shorts closing it seems, which means we may be due a further gain once they eventually decide to cut their losses. There are more questions about Tom Winnifrith than there are about Telit, he has some nerve to question anyone's integrity.

Another high profile connection after the Tesla order. Certainly makes Tom Winnifrith and co look like desperate fools. I read through all of his 'dossier and investigated all the claims he made, especially against the "bogus distributors". Have a look for yourselves guys, they are ALL listed on Telit's website, seem legitimate to me. Certainly don't look like Hanoi bike shops or websites designed by a 5 year old. People like TW are the ones who need investigated. Shame people will take their word for gospel without doing any additional research themselves. Point of the story - global behemoths like AT&T and Tesla don't do business with fictitious and/or fraudulent companies. No doubt there were some questions about the integrity of senior management, but it is far from a "Globo Mk2". GLA

I have literally ran out of money to out into this, unfortunately been buying this since 1800p and itv since 200p and have had to buy more and more of both until now...no money left only hope lol. GLA

So now the market is pricing in 0 growth for this stock. I appreciate 2017 is a tough year for hikma but the price now and price targets set by HSBC and Jefferies suggest that there is 0 growth which is absolutely ridiculous. Yes, we all have to accept that advair even when approved won't be a blockbuster for the company, but have a look at the website and guess what, they are not reliant on one product!! There are circa 50 launches planned for H2 2017!! No growth!?!?! Give me a break! GLA

First of all as already pointed out by someone else, the stock was in auction for a period and offer was quoted at 109.75, FACT. Now with respect to Goldman buying, you post this as though we should take comfort when their overall stake reduced from 7.09% to 6.16% in most recent RNS, yet you say 'Goldman are buying so this must be a winner'. 0.46% of their position is classified as 'Stock Loan (Physical)' with a further 5.58% 'unclassified', FACT. Who can interpret this as a long only position? I have also NEVER provided any prediction or a definitive view on where the share price is headed, FACT, nobody knows and I have stated this multiple times. I am long, only because I think the company isn't going bankrupt, people who disagree are obviously short, that's how any market works, buyers and sellers, FACT. Finally, I am a CFA Charterholder, none of you are anywhere near as qualified an investment professional as I am and you never will be, FACT. For as long as people like moni and Edwina flood this board with absolutely useless nonsense, I will refrain from visiting, because you have both ruined this board. Best of luck to the rest of you.

No news yet, Buy showing at 109.75 now...

Now over 5%. Can't understand why new shorter would enter when the stock has already fallen so much this year!?

I see you're still contributing absolutely useless comments

Goldman are not buying, read all the RNS properly. They are more likely facilitating all the short activity and probably engaging in some themselves. They do not have a straightforward long position and do not hold all their quoted % in ordinary shares it is a combination of complex financial instruments. Nobody should take any comfort from the Goldman holdings

Buy quoted @ 116 right now...

I've already said multiple times here that "short/long we're all taking a punt", nobody knows which way this is headed. Your just stating the obvious, just repeating what every one else has already said. Moron

I have been buying from £18 all the way down, most recent at 1212p now I'm forced to buy more I have so many shares already I'm really taking a huge beating on this one. Cannot understand and unfortunately the technical just point lower and lower. Painful to watch, I'm stuck with it so just have to wait....and wait...

Check out the big brains on this guy. Thanks for your valuable contribution, I'm sure everyone found it most useful...

I was on the conference call at 9.30am this morning. Management confirmed around 50 new launches in H2, on top of the 70+ launched in H1. The strengthening of the Takeda partnership has led to more new drugs being introduced in the MENA region. No new bad news except for the guidance being trimmed again. A couple of analysts quizzed the progress with advair again, nothing new here and given the nature of the process they couldn't go into any specific detail, but confirmed good progress made and that the FDA did have "major" issues with their original application. Again, nothing new. So really the shares have now fallen c65% this year because 2017 revenue is going to be c10% less than originally expected??? I'm really lost for words and have no option now (still sitting on c20% loss) but to buy more and average down. There is nothing in today's update that has made me worried in any way or makes me think this company is now a POS. It is now obscenely oversold (as if it wasn't already!!)

Not enough to stop the rot unfortunately, looks like we're falling again. H1 revenue of $895M is decent but not enough. However, today's announcement is enough that I can average down meaningfully today. Given the share price decline, I think a c10% downward revision in FY revenue from original estimates, is more than priced in already! This requires patience, but I'm betting a year from now things will be looking alot better. GLA

Lagoda and Lazarus look like they have opened up significant long positions in TCM. The Goldman activity is less clear, they have trimmed whatever position they had but it wasn't a straightforward purchase of shares in the first place. Were they shorting? 665,054 shares are categorised as a 'Stock Loan' (Physical), then you have a further 7m+ 'financial instruments' with voting rights attached, which are unclassified, just says "refer to the annexure" - I couldn't find anything.. Either way the volatility has abated somewhat this morning. GLA

@Rich love your optimism but try to respond with a bit more respect in future instead of personally attacking people with an alternative view, in such a childish manner. Everyone should be able to contribute without being berated by you. I'm not sure what your agenda is but please, grow up. Before you slate me as some moron who doesn't know anything, I'm a CFA Charterholder. I share your optimism on the stock but also fully appreciate the doubters comments as their points are absolutely valid. The company isn't exactly glowing with integrity and good corporate governance. I can completely understand why people would avoid it like the plague. I'm just taking a gamble here that the company isn't going bankrupt, I feel it operates in a high-growth sector and has serious potential if nothing more sinister is uncovered in the coming days/weeks. Would I recommend this stock to clients? Absolutely not. As confident as you may be, nobody (long/short) can be confident about the future here. The bottom line, long/short, we are all 'taking a punt'.

Although Norges trimmed their position there is still a fair bit of institutional ownership here which is encouraging at least. I see the capitalisation of internally generated development costs as an "accounting red flag" posted again and again here, but nobody mentions this is completely in line with International Financial Reporting Standards, this is a legitimate accounting practice and hasn't artificially inflated profits. These assets are amortized over their useful lives, again fully within IFRS guidance. High growth technology companies tend to invest alot in R&D, it is normal for qualifying costs to be capitalised. I agree, an increase in revenues and profits over the years without a corresponding increase in cash flow does ring alarm bells. I'm not suggesting the company is squeaky clean, but I don't think they're going bust. Given the space they operate in, if they can get through this uncertainty, the future is still bright. GLA

Has also narrowed significantly, the tightest spread I've seen since before the bad news started to hit. Rising on high volumes, solid rns from management this morning. All good signs. Fingers crossed. GLA

Much higher than normal, shorts closing?